Market Place
Sourcing Support
Whitefort Sends Letter to Arbutus Biopharma Board
03 Dec 2024 //
BUSINESSWIRE
Arbutus to Participate in HC Wainwright @ Home Virtual Chat
26 Nov 2024 //
GLOBENEWSWIRE
Arbutus & Barinthus Report Nivolumab raise HBsAg Loss in Hepatitis B
15 Nov 2024 //
GLOBENEWSWIRE
Arbutus’ Imdusiran Achieves Functional Cure in cHBV with Interferon
15 Nov 2024 //
GLOBENEWSWIRE
Arbutus to Present at Jefferies London Healthcare Conference
14 Nov 2024 //
GLOBENEWSWIRE
Arbutus Reports Q3 2024 Financial Results & Corporate Update
06 Nov 2024 //
GLOBENEWSWIRE
Arbutus Q3 2024 Financial Results and Corporate Update
23 Oct 2024 //
GLOBENEWSWIRE
Arbutus Announces Abstracts Highlighting Imdusiran Data Accepted
15 Oct 2024 //
GLOBENEWSWIRE
Arbutus to Present at H.C. Wainwright Viral Hepatitis Conference
01 Oct 2024 //
GLOBENEWSWIRE
Arbutus to Participate in Two Upcoming Investor Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Arbutus Reports Q2 2024 Results And Corporate Update
01 Aug 2024 //
GLOBENEWSWIRE
UniQure, Arbutus, HilleVax Announce Layoffs
01 Aug 2024 //
FIERCE BIOTECH
Arbutus To Report Q2 2024 Results And Provide Corporate Update
18 Jul 2024 //
GLOBENEWSWIRE
Arbutus: Imdusiran+IFN Achieves Sustained HBsAg Undetectability
05 Jun 2024 //
GLOBENEWSWIRE
Arbutus to Present Imdusiran Data at EASL Congress 2024
22 May 2024 //
GLOBENEWSWIRE
Whitefort Publishes Open Letter On Maximizing Arbutus Value
17 May 2024 //
BUSINESSWIRE
Arbutus CSO Michael Sofia Retiring Dec 31, 2024
02 May 2024 //
GLOBENEWSWIRE
Arbutus Reports First Quarter 2024 Financial Results
02 May 2024 //
GLOBENEWSWIRE
Arbutus Announces Claim Ruling in its Ongoing Patent Infring Against Moderna
04 Apr 2024 //
GLOBENEWSWIRE
Judge Rules Against Moderna in COVID-19 Patent Fight with Roivant Subsidiary
04 Apr 2024 //
BIOSPACE
Moderna shares fall after judge sides with Arbutus in patent fight
04 Apr 2024 //
REUTERS
Arbutus to Participate in Two Upcoming Investor Conferences
08 Mar 2024 //
GLOBENEWSWIRE
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results
15 Feb 2024 //
GLOBENEWSWIRE
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from VTP-300
09 Nov 2023 //
GLOBENEWSWIRE
Arbutus Announces CEO, William Collier, to Retire December 31, 2023
07 Nov 2023 //
GLOBENEWSWIRE
Arbutus Reports Third Quarter 2023 Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Arbutus to Present at H.C. Wainwright 4th Annual HBV Virtual Conference
18 Oct 2023 //
GLOBENEWSWIRE
Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD
11 Oct 2023 //
GLOBENEWSWIRE
Arbutus ends COVID, RNA destabilizer plans over preclinical data
12 Sep 2023 //
FIERCE BIOTECH
Arbutus Announces Dosing of First Subject in the Phase 1a/1b Trial with AB-101
11 Sep 2023 //
GLOBENEWSWIRE
Arbutus to Participate in Two Upcoming Investor Conferences
07 Sep 2023 //
GLOBENEWSWIRE
Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update
03 Aug 2023 //
GLOBENEWSWIRE
Arbutus to Report Q2 2023 Financial Results and Provide Corporate Update
20 Jul 2023 //
GLOBENEWSWIRE
Arbutus Appoints Melissa V. Rewolinski, PhD to its Board of Directors
12 Jul 2023 //
GLOBENEWSWIRE
Arbutus Appoints Two New Executives
10 Jul 2023 //
GLOBENEWSWIRE
Arbutus Presents Preliminary AB-729 & Pegylated Interferon Alfa-2a Combination
21 Jun 2023 //
GLOBENEWSWIRE
Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple
21 Jun 2023 //
GLOBENEWSWIRE
Arbutus previews Hepatitis B RNAi treatment data
07 Jun 2023 //
CLINICAL TRIALS ARENA
Arbutus to Present AB-729 and AB-836 Data at EASL Congress 2023
07 Jun 2023 //
GLOBENEWSWIRE
Arbutus to Present at Jefferies Healthcare Conference
31 May 2023 //
GLOBENEWSWIRE
Arbutus to Present at JMP Securities Life Sciences Conference
09 May 2023 //
GLOBENEWSWIRE
Arbutus Provides AB-729 Clinical Data and AB-161 Preclinical Data
27 Apr 2023 //
GLOBENEWSWIRE
Arbutus` oral checkpoint inhibitor slapped with clinical hold
26 Apr 2023 //
FIERCE BIOTECH
Arbutus Announces FDA Clinical Hold on IND Application for AB-101
25 Apr 2023 //
GLOBENEWSWIRE
Arbutus to Report 1Q 2023 FYR and Provide Corporate Update
20 Apr 2023 //
GLOBENEWSWIRE
Arbutus to Present AB-729 and AB-161 Data at the Global Hepatitis Summit 2023
18 Apr 2023 //
GLOBENEWSWIRE
Court upholds prior strike of Arbutus patent in Moderna case
12 Apr 2023 //
FIERCE PHARMA
Moderna notches a win in long-running Arbutus patent fight
12 Apr 2023 //
ENDPTS
Arbutus files patent lawsuit against Pfizer/BioNTech over COVID vaccines
05 Apr 2023 //
REUTERS
Arbutus Doses First Subject in PI Trial with its Oral RNA Destabilizer, AB-161
16 Mar 2023 //
GLOBENEWSWIRE
Arbutus Presents AB-343 Data at International Conference on Antiviral Research
14 Mar 2023 //
GLOBENEWSWIRE
Moderna loses bid to shift liability in COVID-19 vaccine patent case
11 Mar 2023 //
REUTERS
Arbutus Reports Fourth Quarter and Year End 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
Arbutus to Report Fourth Quarter and Year End 2022 Financial Results
16 Feb 2023 //
GLOBENEWSWIRE
U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit
15 Feb 2023 //
REUTERS
Arbutus to Participate in Three Upcoming Investor Conferences
06 Feb 2023 //
GLOBENEWSWIRE
Arbutus Announces Resignation of Board Member
27 Jan 2023 //
GLOBENEWSWIRE
Arbutus Completes Enrollment in its Phase 2a Clinical Trial Combining AB-729
13 Dec 2022 //
GLOBENEWSWIRE
Drugs up for sale, on the shelf in biotech pipeline clear-outs
09 Nov 2022 //
FIERCEBIOTECH
Moderna`s motion to dismiss patent suit denied by federal judge
04 Nov 2022 //
FIERCEPHARMA
